Detection of fetal structural anomalies in a basic first-trimester screening program for aneuploidy

Bryann Bromley1, Thomas D Shipp2, Jennifer Lyons2

  • 1Diagnostic Ultrasound Associates, PC, Boston, Massachusetts USA (B.B., T.D.S., Y.G., B.R.B.); Department of Obstetrics and Gynecology, Massachusetts General Hospital, Boston, Massachusetts USA (B.B., B.R.B.); Departments of Obstetrics and Gynecology (B.B., T.D.S., S.N., Y.G., B.R.B.) and Radiology (B.B., T.D.S., B.R.B.), Brigham and Women's Hospital, Boston, Massachusetts USA; Department of Epidemiology, Boston University School of Public Health, Boston, Massachusetts USA (J.L.); and Harvard Vanguard Medical Associates, Boston, Massachusetts USA (R.S.N.). bbsono@aol.com.

Summary

First-trimester aneuploidy screening sonography performed by credentialed sonographers effectively detects major and lethal fetal anomalies. This early detection during the 11-14 week gestation period is crucial for timely intervention and management.